Serum osteoprotegerin is independently associated with peripheral arterial stiffness, assessed by brachial-ankle pulse wave velocity, in patients with chronic kidney disease.
Is circulating osteoprotegerin associated with peripheral arterial stiffness in patients with chronic kidney disease?
This study investigates the potential role of circulating osteoprotegerin as a biomarker for peripheral arterial stiffness in chronic kidney disease.
Absolute Event Rate: 0% vs 0%
Peripheral arterial stiffness (PAS) is prevalent in chronic kidney disease (CKD) and contributes to cardiovascular risk. We investigated whether circulating osteoprotegerin (OPG), a cytokine linked to vascular calcification, is associated with PAS assessed by brachial-ankle pulse wave velocity (baPWV) in CKD.
Wang et al. (Wed,) reported a other. Serum osteoprotegerin is independently associated with peripheral arterial stiffness, assessed by brachial-ankle pulse wave velocity, in patients with chronic kidney disease.